Adjustment of the GRACE Score and SHAP Analysis in STEMI Patients

Jin Cao1, Jingyi Liu2, Xiaoqiang Wang3

  • 1College of Mathematics, Taiyuan University of Technology, Taiyuan, Shanxi 030024, PR China.

Insights

This study refines the GRACE risk score for ST-segment elevation myocardial infarction (STEMI) patients. The new GRACE-STEMI score improves mortality prediction and identifies novel risk groups for personalized care.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Biostatistics

Background:

  • The Global Registry of Acute Coronary Events (GRACE) risk score is established for acute coronary syndrome but needs refinement for ST-segment elevation myocardial infarction (STEMI).
  • Accurate risk stratification is crucial for managing STEMI patients and predicting major cardiovascular events.

Purpose of the Study:

  • To develop and validate an adjusted GRACE risk score specifically for STEMI patients to enhance mortality prediction.
  • To identify key predictors of out-of-hospital all-cause death (ACD) in STEMI patients.

Main Methods:

  • Retrospective analysis of ACD incidence and correlation with GRACE score indicators.
  • Adjustment of GRACE scores by reducing contributions from insignificant indicators.
  • Development of the GRACE-STEMI score using a Stacking ensemble method with multiple regression models.
  • Validation using SHAP (Shapley Additive exPlanations) analysis for interpretability.

Main Results:

  • Identified nine key variables influencing the adjusted GRACE score: LA, LVEF, neutrophil percentage, lymphocytes, urea, systolic pressure, admission heart rate, age, and Killip classification.
  • The GRACE-STEMI adjusted model achieved an adjusted R2 of 0.7886 and a C-index of 0.8521.
  • The model demonstrated strong performance on the test set with MSE of 250.8 and RMSE of 15.84.
  • SHAP analysis confirmed model interpretability and identified novel risk factors.

Conclusions:

  • The GRACE-STEMI score adjusted model provides a more precise tool for risk stratification and mortality prediction in STEMI patients.
  • Integration of SHAP analysis enhances interpretability and aids in identifying new risk groups for personalized clinical decision-making.
  • This refined score represents a clinically relevant advancement for STEMI patient management.
Abstract